Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 11:13:175.
doi: 10.3389/fnins.2019.00175. eCollection 2019.

Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder

Affiliations
Review

Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder

Elisabetta Zucchi et al. Front Neurosci. .

Abstract

The historical view that Amyotrophic Lateral Sclerosis (ALS) as a pure motor disorder has been increasingly challenged by the discovery of cognitive and behavioral changes in the spectrum of Frontotemporal Dementia (FTD). Less recognized and still significant comorbidities that ALS patients may present are prior or concomitant psychiatric illness, such as psychosis and schizophrenia, or mood disorders. These non-motor symptoms disturbances have a close time relationship with disease onset, may constitute part of a larger framework of network disruption in motor neuron disorders, and may impact ALS patients and families, with regards to ethical choices and end-of-life decisions. This review aims at identifying the most common psychiatric alterations related to ALS and its prognosis, looking at a common genetic background and shared structural brain pathology.

Keywords: amyotrophic lateral sclerosis; c9orf72; depression; frontotemporal dementia; psychiatric symptoms and disorders; psychosis.

PubMed Disclaimer

References

    1. Abrahams S., Newton J., Niven E., Foley J., Bak T. H. (2014). Screening for cognition and behaviour changes in ALS. Amyotroph. Lateral Scler. Frontotemporal. Degener. 15 9–14. 10.3109/21678421.2013.805784 - DOI - PubMed
    1. Al-Sarraj S., King A.Smith B., Maekawa S., Bodi I., et al. (2011). p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 122 691–702. 10.1007/s00401-011-0911-2 - DOI - PubMed
    1. Amann B. L., Canales-Rodríguez E. J., Madre M., Radua J., Monte G., Alonso-Lana S., et al. (2016). Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. Acta Psychiatr. Scand. 133 23–33. 10.1111/acps.12440 - DOI - PMC - PubMed
    1. Anderson K. K., Voineskos A., Mulsant B. H., George T. P., Mckenzie K. J. (2014). The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis. Can. J. Psychiatry 59 513–517. 10.1177/070674371405901003 - DOI - PMC - PubMed
    1. Aoki Y., Manzano R., Lee Y., Dafinca R., Aoki M., Douglas A. G. L., et al. (2017). C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain 140 887–897. 10.1093/brain/awx024 - DOI - PubMed